• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[质子泵抑制剂对缓解喉咽反流患者声音嘶哑症状的治疗效果]

[The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux].

作者信息

Luo Huanan, Ma Sijing, Gao Yin, Yan Jing, Hou Jin, Xu Min

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Jun;29(11):997-1001.

PMID:26536702
Abstract

OBJECTIVE

To analyze the therapeutic effect of proton pump inhibitor(PPI) on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux(LPR).

METHOD

The LPR outpatients in ENT department of our hospital(60 cases)complained of hoarseness were enrolled in the study from August of 2013 to October of 2014. All of them were randomly divided into group A and B. The individuals in group A (30 cases) taked golden voice capsule to treat for 3 months, while the individuals in group B (30 cases) taked golden voice capsule and omeprazole to treat for 3 months. The data about reflux symptom index (RSI), reflux finding score (RFS) and voice handicap index (VHI)from the first month to the third month after treatment were recorded and compared group A with group B.

RESULT

The scores of RSI and RFS in patients (60 cases) before treatment were significantly correlated with their VHI (r=0. 823, P<0. 01; r=0. 873, P<0. 01). The score changes of RSI and VHI from the first to the third month after treatment in group B were significantly higher than those in group A (P<0. 01). Meanwhile, the score changes of RFS from the third month after treatment in group B were significantly higher than those in group A (t=8. 307, P<. 01), but the differences were not significant for RFS from the first to the second month after treatment between group A and group B(t=1. 128, P>0. 05; t=0. 376, P> 0. 05).

CONCLUSION

PPI therapy could significantly alleviate the hoarseness symptom in LPR patients.

摘要

目的

分析质子泵抑制剂(PPI)对缓解喉咽反流(LPR)患者声音嘶哑症状的治疗效果。

方法

选取2013年8月至2014年10月在我院耳鼻喉科门诊就诊的60例以声音嘶哑为主要症状的LPR患者纳入研究。将所有患者随机分为A组和B组。A组(30例)服用金嗓散结胶囊治疗3个月,B组(30例)服用金嗓散结胶囊及奥美拉唑治疗3个月。记录治疗后第1个月至第3个月的反流症状指数(RSI)、反流发现评分(RFS)及嗓音障碍指数(VHI)数据,并对A组和B组进行比较。

结果

60例患者治疗前的RSI、RFS评分与VHI均显著相关(r = 0.823,P < 0.01;r = 0.873,P < 0.01)。治疗后第1个月至第3个月,B组RSI及VHI评分变化显著高于A组(P < 0.01)。同时,治疗后第3个月B组RFS评分变化显著高于A组(t = 8.307,P < 0.01),但治疗后第1个月至第2个月A组与B组RFS差异无统计学意义(t = 1.128,P > 0.05;t = 0.376,P > 0.05)。

结论

PPI治疗可显著缓解LPR患者的声音嘶哑症状。

相似文献

1
[The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux].[质子泵抑制剂对缓解喉咽反流患者声音嘶哑症状的治疗效果]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Jun;29(11):997-1001.
2
[Effect of proton pump inhibitort on salivary pepsin concentration in patients with laryngopharyngeal reflux].[质子泵抑制剂对喉咽反流患者唾液胃蛋白酶浓度的影响]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Nov;35(11):965-970. doi: 10.13201/j.issn.2096-7993.2021.11.002.
3
Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux.疑似喉咽反流中喉内镜检查结果、质子泵抑制剂(PPI)反应与 pH 值测量的关系。
Dis Esophagus. 2019 Apr 1;32(4). doi: 10.1093/dote/doy072.
4
Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.年龄对喉咽反流病患者质子泵抑制剂治疗的影响:一项前瞻性多中心研究。
JAMA Otolaryngol Head Neck Surg. 2013 Dec;139(12):1291-5. doi: 10.1001/jamaoto.2013.5556.
5
Laryngopharyngeal reflux: Comparing improvements in reflux symptom index with reflux finding score.喉咽反流:比较反流症状指数与反流性疾病评分的改善情况。
Am J Otolaryngol. 2020 Nov-Dec;41(6):102730. doi: 10.1016/j.amjoto.2020.102730. Epub 2020 Sep 12.
6
The effect of N-acetyl cysteine on laryngopharyngeal reflux.
Acta Med Iran. 2013;51(11):757-64.
7
[Diagnosis and treatment of laryngopharyngeal reflux disease].[喉咽反流病的诊断与治疗]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Aug;25(15):690-1.
8
Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study.三种质子泵抑制剂治疗策略对咽喉反流病的疗效:一项前瞻性随机双盲研究。
Clin Otolaryngol. 2019 Jul;44(4):612-618. doi: 10.1111/coa.13345. Epub 2019 May 6.
9
Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial.藻酸镁与质子泵抑制剂治疗咽喉反流的比较:一项非劣效性随机对照试验。
Eur Arch Otorhinolaryngol. 2022 May;279(5):2533-2542. doi: 10.1007/s00405-021-07219-0. Epub 2022 Jan 15.
10
Is there a role for voice therapy in the treatment of laryngopharyngeal reflux? A pilot study.嗓音治疗在治疗喉咽反流中的作用如何?一项初步研究。
Acta Otorhinolaryngol Ital. 2024 Feb;44(1):27-35. doi: 10.14639/0392-100X-N2742.

引用本文的文献

1
Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT.二级保健中兰索拉唑治疗持续性咽喉症状的随机对照试验(TOPPITS RCT)
Health Technol Assess. 2021 Jan;25(3):1-118. doi: 10.3310/hta25030.
2
A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux.质子泵抑制剂治疗在喉咽反流患者中作用的荟萃分析。
Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3795-3801. doi: 10.1007/s00405-016-4142-y. Epub 2016 Jun 16.